Route 92 Medical Announces $50 Million Series F Extension Equity Financing Route 92 Medical announces $50 million series F extension equity financing to support its commercial expansion.

Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.

Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System Route 92 Medical announces FDA 510(k) clearance for its FreeClimb 54 reperfusion system, part of its growing portfolio of neurovascular devices.

Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.

Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.